Move more (even a little) Exercise improves how your body responds to insulin and can help support GLP-1 signalling
In Eli Lillys SURMOUNT-1 trial, participants taking tirzepatide lost up to 22.5% of their body weight over 72 weeks
blood plasma signaling, and why Tessa is Paul's top pick Ipamorelin Ratios for Women: Why equal blends can cause water retention and the case for keeping Ipa lower relative to Tessa or CJC IGF-1 Sweet Spot on Blood Work: Why 250350 is the optimal range for fat loss, lean muscle, sleep quality, and cognitive function AOD-9604 & SLU-PP-332 Fat Loss Protocols: Proper AOD dosing, fasted cardio timing, and what the latest sloop studies show at higher milligram doses SS-31 Then MOTS-C for Mitochondrial Health: How to sequence them, the loading and maintenance phase for metabolic damage, and managing histamine reactions NAD+ Dosing Done Right and What Happens When You Overdo It: Why 200mg per week is the sweet spot and what happens when you accidentally take 500mg Optimal Blood Work Markers for Testosterone: Total, free, DHEA, and SHBG targets for men and women and why DHEA is a $25 fix most people overlook Male Fertility Protocol: HCG dosing, HMG every other day, N-clomiphene citrate, and why Paul avoids standard clomid BPC-157, Angiogenesis & Cancer Research: What the latest rat model studies show about wound healing vs
94,297 Additionally, hyperglycemia-induced activation of protein PKC affects the expression of VEGF, promotes vasoconstriction, and induces hypoxia
However, glucagon-like peptide-1 (GLP-1) receptor agonists such as tirzepatide which can lead to significant weight loss for those with obesity may have the potential to alleviate OSA
